These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 9603417)
1. Bone marrow transplantation from a cadaveric donor. Kapelushnik J; Aker M; Pugatsch T; Samuel S; Slavin S Bone Marrow Transplant; 1998 Apr; 21(8):857-8. PubMed ID: 9603417 [TBL] [Abstract][Full Text] [Related]
2. Bone-marrow transplantation in severe Gaucher's disease. Rappeport JM; Ginns EI N Engl J Med; 1984 Jul; 311(2):84-8. PubMed ID: 6377066 [TBL] [Abstract][Full Text] [Related]
3. Allogeneic bone marrow transplantation for fucosidosis. Vellodi A; Cragg H; Winchester B; Young E; Young J; Downie CJ; Hoare RD; Stocks R; Banerjee GK Bone Marrow Transplant; 1995 Jan; 15(1):153-8. PubMed ID: 7742750 [TBL] [Abstract][Full Text] [Related]
4. Allogeneic bone marrow transplantation: relation between chimaerism and immunity. Vossen J Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764 [TBL] [Abstract][Full Text] [Related]
5. Bone marrow transplantation in Gaucher's disease: effect of mixed chimeric state. Chan KW; Wong LT; Applegarth D; Davidson AG Bone Marrow Transplant; 1994 Aug; 14(2):327-30. PubMed ID: 7994251 [TBL] [Abstract][Full Text] [Related]
6. Successful bone marrow transplantation in a case of Griscelli disease which presented in accelerated phase with neurological involvement. Tezcan I; Sanal O; Ersoy F; Uckan D; Kiliç S; Metin A; Cetin M; Akin R; Oner C; Tuncer A Bone Marrow Transplant; 1999 Oct; 24(8):931-3. PubMed ID: 10516709 [TBL] [Abstract][Full Text] [Related]
7. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease. Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919 [TBL] [Abstract][Full Text] [Related]
8. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice. Du B; Li DP; Xu KL; Pan XY Chin Med J (Engl); 2005 Mar; 118(6):474-9. PubMed ID: 15788128 [TBL] [Abstract][Full Text] [Related]
9. [Analysis of short tandem repeats with fluorescence labeling polymerase chain reaction to document engraftment following allogeneic bone marrow transplantation]. Xiao L; Guo K; Chen H Zhonghua Xue Ye Xue Za Zhi; 2001 Aug; 22(8):418-22. PubMed ID: 11718093 [TBL] [Abstract][Full Text] [Related]
10. [Study on graft-versus-leukemia effects of donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation]. Du B; Li D; Xu K Zhonghua Xue Ye Xue Za Zhi; 2001 Aug; 22(8):403-7. PubMed ID: 11718089 [TBL] [Abstract][Full Text] [Related]
11. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population. Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551 [TBL] [Abstract][Full Text] [Related]
12. Successful donor cell engraftment in a recipient of bone marrow from a cadaveric donor. Blazar BR; Lasky LC; Perentesis JP; Watson KV; Steinberg SE; Filipovich AH; Orr HT; Ramsay NK Blood; 1986 Jun; 67(6):1655-60. PubMed ID: 3518833 [TBL] [Abstract][Full Text] [Related]
13. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases]. Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932 [TBL] [Abstract][Full Text] [Related]
14. Delayed engraftment and mixed chimerism after HLA-identical sibling donor BMT in Fanconi anaemia. Mital MK; Curtis A; Spencer V; Barge D; Skinner R Bone Marrow Transplant; 1999 Jul; 24(2):201-4. PubMed ID: 10455350 [TBL] [Abstract][Full Text] [Related]
15. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: a focus on the incidence of graft-vs.-host disease and relapse. Ustün C; Arslan O; Beksaç M; Koç H; Gürman G; Ozçelik T; Yilmaz B; Ilhan O; Akan H; Ozcan M; Demirer T; Uysal A; Konuk N; Arat M; Dilek I; Celebi H; Coskun HS Biol Blood Marrow Transplant; 1999; 5(1):28-35. PubMed ID: 10232738 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of allogeneic hematopoietic stem cell engraftment and prevention of GVHD by intra-bone marrow bone marrow transplantation plus donor lymphocyte infusion. Nakamura K; Inaba M; Sugiura K; Yoshimura T; Kwon AH; Kamiyama Y; Ikehara S Stem Cells; 2004; 22(2):125-34. PubMed ID: 14990852 [TBL] [Abstract][Full Text] [Related]
17. Leukaemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anaemia. Lawler M; Locasciulli A; Longoni D; Schiro R; McCann SR Bone Marrow Transplant; 2002 Mar; 29(5):453-6. PubMed ID: 11919737 [TBL] [Abstract][Full Text] [Related]
18. Second transplant for a thalassemia patient after graft rejection: with immunosuppression and allogeneic peripheral blood stem cell. Li CK; Shing MM; Chik KW; Lee V; Tsang KS; Yuen PM Pediatr Hematol Oncol; 2002 Jun; 19(4):267-71. PubMed ID: 12051594 [TBL] [Abstract][Full Text] [Related]
19. [Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center]. van Steekelenburg M; van Weel-Sipman MH; Zwinderman AH; Hoogerbrugge PM; Vossen JM; Egeler RM Ned Tijdschr Geneeskd; 2002 Aug; 146(33):1542-6. PubMed ID: 12212502 [TBL] [Abstract][Full Text] [Related]